Background and aims: to identify heart rate variability (HRV) 
Background and aims

According to
International Diabetes Federation (IDF) 415 million adult people suffer from diabetes mellitus (DM) in the world. The number of cases will reach 642 million people by 2040 with preserving actual trends. Type 1 diabetes mellitus (Type 1 DM) will raise from 7% to 17%. Although Type 1 DM is less common than Type 2 DM, the annual growth is approximately 3% in the world [1] .
Type 1 DM leads to disability in young and middle age, due to progression of its complications (mainly nephropathy and amputations) [2] [3] [4] . Evolving metabolic changes contribute to the development of cardiovascular complications in the patients' employable category that is results both in medical and social problems. Mortality from cardiovascular disease in patients with diabetes is 2-3 times higher than among others [4] [5] [6] . The clinical manifestations of the cardiovascular system involvement in Type 1 DM include resting tachycardia, accompanied by lengthening of the QT interval, the fixed heart rate (syndrome denervation of the heart), and reduced tolerance to physical activity. Also, orthostatic hypotension, and painless myocardial ischaemia are included according to the recommendations of the American Diabetes Association (ADA) [7] .
Lengthened QT interval leads to increased risk of arrhythmias [8, 9] . Ventricular arrhythmias are especially dangerous. They can lead to sudden death due to acute heart failurethe so-called "dead-in-bed" syndrome [10, 11] . Firstly, the clinical value of analysis of heart rate variability (HRV) was revealed in the early 60`. Under physiological conditions, regulation of heart rhythm is the result of automatic cells' rhythmic activity in the sinus node, which modulates the influence of the autonomic and central nervous systems, humoral and reflex effects. The decrease of HRV is regarded as a powerful predictor of sudden cardiac death in patients with cardiovascular disease, as well as among others. In addition, the decrease of HRV is closely associated with the deterioration of the functional state of the cardiovascular system [12] . Technologies were standardized and recommendations for practical use of HRV indexes were developed by the working group of the European society of cardiology and the North American society of pacing and electrophysiology in 1996 [13, 14] .
Nowadays, the unsolved problem of occurrence of hypoglycemic conditions in patients with type 1 diabetes remains. They exert influence on pro-arrhythmogenic action and accelerate the development of both micro -and macrovascular complications of diabetes, despite the new types of insulin.
The aim of the investigation was to reveal changes of heart's rate variability and blood pressure in patients with type 1 diabetes depending on disease's duration and glycemic control.
Materials and methods:
Fourty-three patients with DM (males-23 (53%), females -20 (47%) were examined in the Endocrinology Department of University Clinic of «Dnepropetrovsk Medical Academy» between October 2016 and September 2017.
The diagnosis of diabetes mellitus type 1 was made according to American Diabetes Association criteria -2017.
The inclusion criteria were: males and females with type 1 diabetes, from 18 to 40 years old without arterial hypertension.
The exclusion criteria were: type 2 diabetes; diabetic ketoacidosis at the time of inclusion; secondary DM; body mass index (BMI) > 40 kg/m2; diabetic proliferative retinopathy; chronic kidney diesease IIIB -V; diabetic foot (class II according to Wagner and above); heart failure III / IV by the New York Heart Association (NYHA); congenital and acquired heart disease; acute coronary syndrome, acute ischemic stroke and transient ischemic attack; exacerbation of accompanying chronic diseases; acute physical illness; myocarditis in past history; cancer up to 5 years from the full course of therapy; antiretroviral therapy; diagnosed viral hepatitis B and C; pregnancy.
All patients had signed the voluntary informed consent, approved by the local Ethics Committee before their inclusion in the study. All patients were treated on the basal-bolus insulinotherapy, the daily dose of insulin was 44 ± 3,15 IU. The C-peptide, HbA1c, blood creatinine, the first morning urinary albumin excretion (UAE) were determined for verification and evaluation of control. C-peptide was determined on an electrochemiluminescence automatic immunochemical analyzer COBAS e 411, Roche Diagnostics GmbH & Hitachi, Japan, 2012. The concentration of blood creatinine, HbA1c and microalbumin were determined using automatic biochemical analyzer SAPPHIRE 400, TokioBoeki, Japan, 2009. GFR was calculated according to the formula CKD-EPI [15] .
Long-term monitoring of blood glucose levels was conducted by using the system CGMS (Continuous Glucose Monitoring System, Medtronic MiniMed, USA).
This system detects electrical signals every 10 seconds and transforming them in glucose values every 5 minutes. The boundaries of the measurement of glucose levels by this method range from 2.2 mmol/l to 22.2 mmol/l [16] . The patients performed at least four blood glucose measurements per day using the individual glucose test for the calibration data of the sensor with capillary blood. Hypoglycemia was considered as an episode of lower blood glucose level less than 3.9 mmol/l according to the criteria of ADA [7] .
The daily monitoring of the electrocardiogram (ECG) Holter and extended monitoring of blood pressure (BP) within 24 hours on the unit DigiTrak XT (Philips Medical Systems, USA) were carried out in the free moving regime. It was made in parallel with long term monitoring of blood glucose. The temporal and spectral HRV parameters were examined, which were computed using the software ARNIKA, version 8.3.9.
Analysis of the time domain was carried out using these indicators: SDNN (ms) -the standard deviation of normal intervals RR (NN), which represents the total effect of vegetative regulation of the heart. RMSSD (ms) -the root mean square difference between adjacent RR intervals. It reflects the activity of parasympathetic link of vegetative regulation.
PNN50 (%) -number of consecutive RR intervals, the difference between them is more than 50 ms expressed as a percentage of the total number of RR-intervals, reflecting the degree of predominance of parasympathetic link of regulation over the sympathetic (relative value).
The circadian profile was assessed by the circadian index (CI), which was calculated as the ratio of the average daily to the average night heart rate (HR).
Spectral analysis of HRV was calculated using the algorithm of fast Fourier transform according to the recommendations of the American College of Cardiology and American Heart Association [13]. The power of the four main frequency bands was estimated: high frequency (HF) -0.15-0.40 Hz, low freguency (LF) -0.04-0.15 Hz, very low frequency (very low frequency -VLF) -0.0033-0.04 Hz, as well as total power of the spectrum (TP), the ratio of low frequency components to high frequency (LF / HF) was calculated.
During the day time measuring intervals of BP were 15 minutes, and at night -30 min. one time per hour (according to the recommendations of the Scientific Committee in the field one day monitoring of BP (DMBP) 1990). According to DMBP the average systolic blood pressure (SBP), mean diastolic blood pressure (DBP), the average level of pulse pressure (PBP) were calculated. These indicators were calculated per day, as well as for the period of sleep and wakefulness. The circadian profile of BP was evaluated by calculating the daily index of SBP and DBP, as well as the magnitude and rate morning blood pressure increase.
Echocardiography examination was carried out for studying of cardiac hemodynamics and determining the contractility of the myocardium to exclude organic pathology. Standard methods were used on the apparatus "PHILLIPS HD3". Aorta, left atrium, right atrium, interventricular septum, and posterior wall thickness, left ventricle in systole and diastole, and the right ventricle were evaluated. Left ventricular ejection fraction was determined. Reference values for were provided by the American Society of Echocardiography in conjunction with the European Association of Cardiovascular Imaging [17] .
Statistical analysis
The statistical analysis was conducted using the licensed software package "Statistica 6.1" (StatSoftInc). Comparison between groups was carried out by the independent t-test (for parametric data) or the test of Mann-Whitney (nonparametric test). Data with Gaussian distribution were expressed as mean and standard deviation (M±SD). The data were described by median and quarterly ranges (Me (25%; 75%) when their normal distribution was not validated. the Chi 2 test for the comparison between two percentages and the analysis of variance for the comparison between several means. Differences were considered statistically significant at p < 0.05.
Results
Average age of patients -27,6 ± 2,49 years, disease duration -10,8 ± 1,46 years, BMI 22,6 ± 0,62 kg / m 2 Patients were divided into 2 groups according to the level НвА1с: group 1 (n=21) with НвА1с ≤ 7,5 % and group 2 (n=22) with НвА1с > 7,5 %. There were no statistical differences between groups in age, duration of disease, the basic anthropometric indexes, daily dose of insulin, the level of daily BP, the GFR level, and did not differ by the frequency of hypoglycemia, (Table 1) , as well as on spectral and temporal characteristics of HRV ( Table 2) .
The correlation analysis for the duration of Type 1 DM revealed increasing LF / HF (r=0.383; p=0.045), increasing SBP at night (r=0.372; p=0.039) and for 24 hours (r=0.386; p=0.046). Indicators of DBP to the greater extent changed the course of the disease. The direct positive correlation between the duration of Type 1 DM and the increase in the average DBP for 24 hours (r=0.446; p=0.025), mean DBP during the day (r=0.396; p=0.021), mean DBP at night (r=0.537; p=0.020) were revealed, too (Figure 1) . Also, this positive correlation was revealed in increasing of daily performance of the diastolic pressure area index (DPAI24) (r=0.422; p=0.028), area index of night DBP (r=0.414; p=0.032), and daily performance of the diastolic pressure time index (DPTI24) (r=0.411; p=0.033), time index of night DBP (r=0.428; p=0.026). Additionally, the increase in the duration of the disease was accompanied by deterioration in glycemic control, assessed by HbA1c level (r=0.381; p=0.046).
The presence of hypoglycemic episodes affected both on the temporal and spectral HRV indices, irrespective of the level of HbA1c (Table 3 ). The frequency of hypoglycemic episodes increased with increasing duration of Type 1 DM (r=0.4; p=0.026). The groups were divided into subgroups according to the absence (A) or presence (B) of hypoglycemia (Table 4) . Among all BP monitoring parameters the DPAI24 and DPTI24 are the most validative for confirmation of hypoglycemic episodes. In our study was showed DPAI24 6.80,0 (3.30; 10.6) vs 5.20 (1.45; 14.35) (p=0.016), and DPTI24 6.4 (0.9; 15.4) as against 5.75 (2.35; 12.85) (p=0.025), compareing groups 2B and 2A. Comparable data were obtained in group 1: DPAI24 11.5 (0; 13.1) vs 4.3 (0;13.9) (p=0.012), and DPTI24 15.5 (0;14.2) as against 4.4 (0;14.1) (p=0.001), compareing groups 1B and 1A.
Discussion
We confirmed in our study results showed da Silva A.K. et al., 2017, found that patients with type 1 diabetes had a significant decrease in HRV time values, such as RMSSD, PNN50% [18] . In another study da Silva T.P. et al., 2017, studied the spectral analysis of HRV in patients with Type 1 DM. Patients with moderate and severe hypoglycemia were older, had a longer duration of diabetes, which correlated with the astonishment of chronic complications. The authors observed a lower HRV in the highfrequency spectral analysis band, and an increase in the LF / HF index [19] .
We showed that hypoglycemic conditions lead to further progression of autonomic dysfunction and even greater reduction of HRV, namely, RMSSD, pNN50%, and an increase in the LF / HF index. The increase of duration Type 1 DM was accompanied by deterioration in glycemic control, assessed by HbA1c level (r = 0.381; p = 0.046) and increased the frequency of hypoglycemia (r = 0.4; p =0.046). Similar results were obtained by Limberg J.K. et al. 2015 , which showed that these rates decreased even more during episodes of hypoglycemia [20] . All this changes leads to cardiovascular death.
Although the duration of disease leads to an increase in SBP (r=0.386; p=0.046) and DBP (r=0.446; p=0.025), but the growth of DPAI24 and DPTI24 correlated with the presence of a hypoglycaemic episodes.
Thus, hypoglycemia has negatively affects in cardiovascular functiob both by reducing the temporal and spectral parameters of HRV, and at the expense of increasing DBP, which in turn further reduces the autonomic cardiac activity.
Conclusions
The determination of RMSSD, pNN50%, LF, HF and LF / HF is the most reliable criteria for the evaluation of changes of heart rate variability in patients with Type 1 DM.
The increase the duration of type 1 diabetes has the correlation with the decrease of HRV as by time and frequency indicators, namely, the decrease in RMSSD, pNN50% and the increase of LF/HF are observed.
Hypoglycemia is the key factor leading to the decline in HRV indices, namely RMSSD, pNN50% and increased LF/HF. The incidence of hypoglycaemia episodes increases with duration of type 1 diabetes, regardless of HbA1c indicator.
The daily variability of BP in patients with type 1 diabetes is realized through the changes of DBP. The duration of the disease has the significant correlation with the increase in the average DBP during the day and in periods of sleep and wakefulness, increased DPAI24.
All the above findings demonstrate the need to reduce the frequency of hypoglycaemic episodes in patients with T1DM, as its impact on HRV and BP, regardless of glycaemia control and duration of disease affects the functional state of the cardiovascular system in a negative mode.
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